VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 24, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today that it entered into a consulting service with Matrix Medika, a developer of medical systems specialized in assisting companies in obtaining regulatory approval for medical devices under development. The service will be given as part of the agreement with Arkit Studio, a company that provides the service of characterization and design for the EZ-G Device. Matrix Medika will assist BYND Cannasoft by granting expert opinion and market research about the regulatory approval process for the Company's EZ

6-K - Femto Technologies Inc. (0001888151) (Filer)

6-K - Femto Technologies Inc. (0001888151) (Filer)

6-K - Femto Technologies Inc. (0001888151) (Filer)

6-K - Femto Technologies Inc. (0001888151) (Filer)

6-K - Femto Technologies Inc. (0001888151) (Filer)

6-K - Femto Technologies Inc. (0001888151) (Filer)

6-K - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)

EFFECT - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)

6-K - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)

POS AM - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)

NEW YORK, NY / ACCESSWIRE / March 18, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN).About BYND Cannasoft Enterprises Inc.BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel. The company owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, personnel management, marketing, call centre, and asset management activities; and develops New Cannabis CRM platf

ASHKELON, Israel and VANCOUVER, British Columbia, Jan. 25, 2024 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today that its EZ-G project team has arrived in Shenzhen, China to sign agreements with two of the largest manufacturers in the province to begin production of the EZ-G device and EZ-G Capsules. BYND Cannasoft intends to start mass production of its EZ-G device and EZ-G capsules after the Chinese New Year which ends on February 24, 2024. Starting production of the EZ-G device and EZ-G capsules will allow BYND Cannasoft to meet its benchmark of starting the sale of the EZ-G device and EZ-G capsules in the s

NEW YORK, NY / ACCESSWIRE / December 21, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN).About BYND Cannasoft Enterprises Inc.BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel. The company owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, personnel management, marketing, call centre, and asset management activities; and develops New Cannabi

ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today a significant milestone in its intellectual property strategy as its Zigi Carmel Initiatives & Investments LTD subsidiary filed a national phase application for Its EZ-G Device. A national phase application corresponding to inventive concept III of PCT/IL2022/050783 was filed on December 7, 2023, as a U.S. utility patent application under the Patent Prosecution Highway (PPH) and has been allocated the application number 18/567,766. The Company also announced filing in 11 additional jurisdictions, inc

Israel's Finance Ministry has increased the Israel Innovation Authority's Fast-Track Fund up to US$100 Millioni, Empowering its high-tech sector amid wartime challengesIsrael-based BYND Cannasoft has submitted a research and development plan to develop CRM software combined with AI for the medical cannabis industry ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company"), announced today on submitting a research and development plan based on a planned budget of US$1.5 million (grant of up to US$0.75 million) to develop CRM software combined with AI for the medical cannab

ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company"), announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical cannabis in Israel. Recent regulatory reforms approved by the Israeli Ministry of Healthi allows physicians to prescribe cannabis to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical cannabis patientsii in the wake of recent events, particularly the opening of the war in Gaza. This

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) ("BYND" or the "Company") has released its financial results for the six-month period ended June 30, 2023. Full versions of BYND's unaudited consolidated interim financial statements and management discussion and analysis for the period can be found on www.sedar.com. Q2 2023 Financial Highlights: Revenue increased 21% to $251,047 in Q2 2023 from $207,653 in Q2 2022.Gross Profit decreased to 57% for the six-month period ended June 30, 2023, from 59% in 2022.Net loss increased 242% to $1,147,324 in Q2 2023 from $473,386 in Q2 2022.Working capital decreased to 1,021,170

ASHKELON, Israel and VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") today announced that Yftah Ben Yaackov, Chief Executive Officer and Director, shared a comprehensive update on the Company's progress, highlighting significant recent milestones and unveiling promising prospects for the future. Since acquiring Zigi Carmel Initiatives & Investments LTD., BYND Cannasoft has been planning the development of three products for the sexual wellness market, including our A.I.-based EZ-G device, an A.I.-based smart treatment device for men, and an A.I.-based smart treatment device for wome

ASHKELON, Israel and VANCOUVER, British Columbia, July 31, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today Zigi Carmel Initiatives & Investments LTD, a wholly owned subsidiary of BYND Cannasoft, has filed a patent application for its AI based EZ-G device with the World Intellectual Property Office, also known as WIPO. The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023. The WIPO application specifically relates to adult toys utilizing one or more sensors for controllab

ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced several milestones for the second half of 2023 on the development of its groundbreaking EZ-G Device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, could enhance therapeutic approaches for women's health issues by offering cutting-edge technology to cater to the evolving needs of consumers. Moreover, the company is actively negotiating with synergistic businesses, particularly those in the CBD oils sector, for a transformative transaction.  BYND Cannasoft is pleased to

Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers MultiMetaVerse Holdings Limited (NASDAQ:MMV) shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. (NASDAQ:GTBP) rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Hold

Shares of Agenus Inc. (NASDAQ:AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ:AGEN) declined 17% to $0.4181 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Auddia Inc. (NASDAQ:AUUD) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers. Longeveron Inc. (NASDAQ:LGVN) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering. UTime Limited (NASDAQ:WTO) gained

Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations. Esperion Therapeutics shares climbed 7.1% to $3.47 pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Longeveron Inc. (NASDAQ:LGVN) rose 93.2% to $4.25 in pre-market trading after gaining 8% on Friday. Antelope Enterprise Holdings Limited (NASDAQ:AEHL) shares rose 47% to $2.20 in pre-market trading after declining 5% on Friday. On April 1, Antelope Enterprise announced preliminary full year 2023 revenue of $70.4 mil

Shares of Ulta Beauty, Inc. (NASDAQ:ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers ARCA biopharma, Inc. (NASDAQ:ABIO) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement. Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences. Next Technology Holding Inc. (NASDAQ:NXTT) rose 57.4% to $6.42. Vanda Ph

Shares of Cal-Maine Foods, Inc. (NASDAQ:CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from Benzinga Pro. Cal-Maine Foods shares jumped 8.3% to $63.80 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers LAMF Global Ventures Corp. I (NASDAQ:LGVC) rose 148.9% to $26.79 in pre-market trading. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd. Aesthetic Medical International Holdings

Cannasoft Enterprises (NASDAQ:BCAN) announced on Tuesday the halt of their medical cannabis growing facility's construction to pivot towards the Femtech sector. Cannasoft, an Israeli cannabis company, carried out successful fundraising last month but has now decided to redirect the funds to its new business strategy: female tech wellness. Attempts to redirect its business plans are driven by the negative shifts in the global medical cannabis market. Also, the ongoing war involving Israel, and the facility's location near the Gaza border, raised security concerns about the construction plans. The board plans to review this decision in July 2024. Looking Forward: Femtech And Cannabis Cannas

Shares of Westport Fuel Systems Inc. (NASDAQ:WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ:STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ:CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-q

Shares of Landos Biopharma, Inc. (NASDAQ:LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE:ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Next.e.GO N.V. (NASDAQ:EGOX) shares jumped 85.8% to $0.0730 after falling around 22% on Friday. Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares climbed 70.1% to $2.9255 after the company announced a collaboration with Univercells Group on nanoparticle-delivered mRNA vaccines. MicroAlgo Inc. (NASDAQ:MLGO) climbed 34.3% to $5.40 a

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) rose sharply in today’s pre-market trading following fourth-quarter results. Salarius Pharmaceuticals posted a net loss of $0.9 million, or 22 cents per share for the fourth quarter, narrower than the year-ago loss of $6.4 million, or $2.83 per share, according to data from Benzinga Pro. Salarius Pharmaceuticals shares jumped 31.4% to $0.8149 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Next.e.GO N.V. (NASDAQ:EGOX) shares rose 85.8% to $0.0730 in pre-market trading after falling around 22% on Friday. MicroAlgo Inc. (NASDAQ:MLGO) rose 56.7% to $6.30 in pre-market trading after declining a

Shares of Cutera, Inc. (NASDAQ:CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results. Cutera posted adjusted loss of $1.36 per share, compared to market estimates for a loss of 94 cents per share. The company’s quarterly sales came in at $49.540 million, versus expectations of $47.500 million, according to data from Benzinga Pro. Cutera shares dipped 26.5% to $1.6899 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Murano Global Investments PLC (NASDAQ:MRNO) shares jumped 147.5% to $23.94 after falling 46% on Thursday. Nova LifeStyle, Inc. (NASDAQ:NVFY) surged 120% to $4.0301 afte